All Stories

  1. Challenging the Macrocycle Paradigm: Four-Arm, High-Denticity Acyclic Chelators for Radiopharmaceuticals Incorporating Actinium and Lanthanides
  2. Evaluating a triaza-18-crown-6 picolinate chelator for [212/203Pb]Pb2+ and [212/213Bi]Bi3+ theranostics
  3. H3trica: Versatile Macrocyclic Chelator for [225Ac]Ac3+ and [155/161Tb]Tb3+ Theranostics
  4. H2ampa─Versatile Chelator for [203Pb]Pb2+, [213Bi]Bi3+, and [225Ac]Ac3+
  5. [nat/89Zr][Zr(pypa)]: Thermodynamically Stable and Kinetically Inert Binary Nonadentate Complex for Radiopharmaceutical Applications
  6. H4HBEDpa: Octadentate Chelate after A. E. Martell
  7. Peptide and Small Molecule Inhibitors Targeting Myeloid Cell Leukemia 1 (Mcl-1) as Novel Antitumor Agents
  8. Evaluation of La(XT), a novel lanthanide compound, in an OVX rat model of osteoporosis
  9. Phosphonate Chelators for Medicinal Metal Ions
  10. Recent Advances in Asialoglycoprotein Receptor and Glycyrrhetinic Acid Receptor-Mediated and/or pH-Responsive Hepatocellular Carcinoma- Targeted Drug Delivery
  11. Chemical Promiscuity of Non-Macrocyclic Multidentate Chelating Ligands for Radiometal Ions: H4neunpa-NH2 vs H4noneunpa
  12. Getting a lead on Pb2+-amide chelators for 203/212Pb radiopharmaceuticals
  13. High denticity oxinate-linear-backbone chelating ligand for diagnostic radiometal ions [111In]In3+ and [89Zr]Zr4+
  14. Inorganic radiopharmaceutical chemistry of oxine
  15. Metal ion size profoundly affects H3glyox chelate chemistry
  16. Thorium chelators for targeted alpha therapy: Rapid chelation of thorium‐226
  17. Discovery of a Copper-Based Mcl-1 Inhibitor as an Effective Antitumor Agent
  18. Rapid Thermodynamically Stable Complex Formation of [nat/111In]In3+, [nat/90Y]Y3+, and [nat/177Lu]Lu3+ with H6dappa
  19. Chelation in One Fell Swoop: Optimizing Ligands for Smaller Radiometal Ions
  20. 225Ac-H4py4pa for Targeted Alpha Therapy
  21. Coordination chemistry of [Y(pypa)]− and comparison immuno-PET imaging of [44Sc]Sc- and [86Y]Y-pypa-phenyl-TRC105
  22. tBu4octapa-alkyl-NHS for metalloradiopeptide preparation
  23. Evaluation of the Tetrakis(3-Hydroxy-4-Pyridinone) Ligand THPN with Zirconium(IV): Thermodynamic Solution Studies, Bifunctionalization, and in Vivo Assessment of Macromolecular 89Zr-THPN-Conjugates
  24. Radiopharmaceuticals for diagnosis in nuclear medicine: a short review
  25. Discovery of β-carboline copper(II) complexes as Mcl-1 inhibitor and in vitro and in vivo activity in cancer models
  26. Octadentate Oxine-Armed Bispidine Ligand for Radiopharmaceutical Chemistry
  27. In vitro and in vivo anti-tumor activity of two gold(III) complexes with isoquinoline derivatives as ligands
  28. Radioactive Main Group and Rare Earth Metals for Imaging and Therapy
  29. H4octox: Versatile Bimodal Octadentate Acyclic Chelating Ligand for Medicinal Inorganic Chemistry
  30. H2hox: Dual-Channel Oxine-Derived Acyclic Chelating Ligand for 68Ga Radiopharmaceuticals
  31. Multi-Target Metal-Based Anticancer Agents
  32. Biological Imaging with Medium-Sensitive Bichromatic Flexible Fluorescent Dyes
  33. Biological Imaging with Medium-Sensitive Bichromatic Flexible Fluorescent Dyes
  34. Di- and Trivalent Metal-Ion Solution Studies with the Phosphinate-Containing Heterocycle DEDA-(PO)
  35. A Perspective – can copper complexes be developed as a novel class of therapeutics?
  36. Frontiers in radionuclide imaging and therapy, a chemical journey from naturally radioactive elements to targeted theranostic agents
  37. H4octapa: synthesis, solution equilibria and complexes with useful radiopharmaceutical metal ions
  38. Dipicolinate Complexes of Gallium(III) and Lanthanum(III)
  39. A comparative evaluation of the chelators H 4 octapa and CHX-A″-DTPA with the therapeutic radiometal 90 Y
  40. Novel “bi-modal” H 2 dedpa derivatives for radio- and fluorescence imaging
  41. Synthesis, characterization, and evaluation of the antimicrobial potential of copper(II) coordination complexes with quinolone and p -xylenyl-linked quinolone ligands
  42. In silico to in vitro screening of hydroxypyridinones as acetylcholinesterase inhibitors
  43. Evaluation of H2CHXdedpa, H2dedpa- and H2CHXdedpa-N,N′-propyl-2-NI ligands for 64Cu(ii) radiopharmaceuticals
  44. Gallium(iii) and iron(iii) complexes of quinolone antimicrobials
  45. Harnessing the bone-seeking ability of Ca(ii)-like metal ions in the treatment of metastatic cancer and resorption disorders
  46. Synthesis and characterization of lipophilic cationic Ga(iii) complexes based on the H2CHXdedpa and H2dedpa ligands and their 67/68Ga radiolabeling studies
  47. H2CHXdedpa and H4CHXoctapa—Chiral Acyclic Chelating Ligands for 67/68Ga and 111In Radiopharmaceuticals
  48. Ion Exchange in Hydroxyapatite with Lanthanides
  49. In vivo study and thermodynamic investigation of two lanthanum complexes, La(dpp)3 and La(XT), for the treatment of bone resorption disorders
  50. High-denticity ligands based on picolinic acid for 111In radiochemistry
  51. H6phospa-trastuzumab: bifunctional methylenephosphonate-based chelator with89Zr,111In and177Lu
  52. 3-Hydroxy-4-pyridinone derivatives as metal ion and amyloid binding agents
  53. Structural Characteristics of Chloroquine-Bridged Ferrocenophane Analogues of Ferroquine May Obviate Malaria Drug-Resistance Mechanisms
  54. Werner coordination chemistry and neurodegeneration
  55. In vitro studies of lanthanide complexes for the treatment of osteoporosis
  56. Exploring the multifunctionality of thioflavin- and deferiprone-based molecules as acetylcholinesterase inhibitors for potential application in Alzheimer's disease
  57. Synthesis and in vitro anticancer activity of ferrocenyl-aminoquinoline-carboxamide conjugates
  58. H2azapa: a Versatile Acyclic Multifunctional Chelator for 67Ga, 64Cu, 111In, and 177Lu
  59. The art of building multifunctional metal-binding agents from basic molecular scaffolds for the potential application in neurodegenerative diseases
  60. RGD conjugates of the H2dedpa scaffold: synthesis, labeling and imaging with 68Ga
  61. 1,1′-Disubstituted Ferrocenyl Carbohydrate Chloroquine Conjugates as Potential Antimalarials
  62. Modular Synthesis of 1,2- and 1,1′-Disubstituted Ferrocenyl Carbohydrate Chloroquine and Mefloquine Conjugates as Potential Antimalarial Agents
  63. Evaluation of the H2dedpa Scaffold and its cRGDyK Conjugates for Labeling with 64Cu
  64. H4octapa: An Acyclic Chelator for 111In Radiopharmaceuticals
  65. 1,2-Disubstituted ferrocenyl carbohydrate chloroquine conjugates as potential antimalarial agents
  66. New Ga derivatives of the H2dedpa scaffold with improved clearance and persistent heart uptake
  67. One to chelate them all: investigation of a versatile, bifunctional chelator for 64Cu, 99mTc, Re and Co
  68. N-Aryl-substituted 3-(β-D-glucopyranosyloxy)-2-methyl-4(1H)-pyridinones as agents for Alzheimer's therapy
  69. Biosorbents for hexavalent chromium elimination from industrial and municipal effluents
  70. Acyclic Chelate with Ideal Properties for68Ga PET Imaging Agent Elaboration
  71. Cationic technetium and rhenium complexes with pendant carbohydrates
  72. Dalton Transactions: Increasing Impact
  73. In vitro studies of 3-hydroxy-4-pyridinones and their glycosylated derivatives as potential agents for Alzheimer's disease
  74. Medicinal Inorganic Chemistry Approaches to Passivation and Removal of Aberrant Metal Ions in Disease
  75. Stan Kirschner—An appreciation
  76. Design, Synthesis, and Imaging of Small Amphiphilic Rhenium and99mTechnetium Tricarbonyl Complexes
  77. Calorimetric studies of the interaction between the insulin-enhancing drug candidate bis(maltolato)oxovanadium(IV) (BMOV) and human serum apo-transferrin
  78. Vanadium treatment of type 2 diabetes: A view to the future
  79. Long-chain rhenium and technetium glucosamine conjugates
  80. Glucosamine conjugates bearing N,N,O-donors: potential imaging agents utilizing the [M(CO)3]+ core (M = Re, Tc)
  81. Cytotoxicity of the traditional chinese medicine (TCM) plumbagin in its copper chemistry
  82. Divalent later transition metal complexes of the traditional chinese medicine (TCM) liriodenine: coordination chemistry, cytotoxicity and DNA binding studies
  83. Potential new inorganic antitumour agents from combining the anticancer traditional Chinese medicine (TCM) liriodenine with metal ions, and DNA binding studies
  84. Glycosylated tetrahydrosalens as multifunctional molecules for Alzheimer's therapy
  85. 2008: a record year for Dalton Transactions!
  86. Molecular Architectures for Trimetallic d/f/d Complexes: Magnetic Studies of a LnCu2Core
  87. Molecular Architectures for Trimetallic d/f/d Complexes: Structural and Magnetic Properties of a LnNi2Core
  88. Theoretical Studies of the Tautomers of Pyridinethiones
  89. Pyridine−tert-Nitrogen−Phenol Ligands: N,N,O-Type Tripodal Chelates for the [M(CO)3]+Core (M = Re, Tc)
  90. Dalton Transactions: providing the best services
  91. 99m-Technetium carbohydrate conjugates as potential agents in molecular imaging
  92. Altering pyridinone N-substituents to optimise activity as potential prodrugs for Alzheimer's disease
  93. 55Cobalt complexes with pendant carbohydrates as potential PET imaging agents
  94. Synthesis, Characterization, and Metal Coordinating Ability of Multifunctional Carbohydrate-Containing Compounds for Alzheimer's Therapy
  95. Combating Alzheimer's Disease With Multifunctional Molecules Designed for Metal Passivation
  96. Lanthanide containing compounds for therapeutic care in bone resorption disorders
  97. Vanadium in diabetes: 100 years from Phase 0 to Phase I
  98. Synthesis, Structure, and Biological Activity of Ferrocenyl Carbohydrate Conjugates
  99. Carbohydrate-Appended 3-Hydroxy-4-pyridinone Complexes of the [M(CO)3]+Core (M = Re,99mTc,186Re)
  100. Glucosamine Conjugates of Tricarbonylcyclopentadienyl Rhenium(I) and Technetium(I) Cores
  101. Lanthanide(iii) and group 13 metal ion complexes of tripodal amino phosphinate ligands
  102. Metal complexes of maltol and close analogues in medicinal inorganic chemistry
  103. Metal complexes in medicinal chemistry: new vistas and challenges in drug design
  104. Design of targeting ligands in medicinal inorganic chemistry
  105. Editorial: Lanthanide compounds for therapeutic and diagnostic applications
  106. Carbohydrate-Bearing 3-Hydroxy-4-pyridinonato Complexes of Gallium(III) and Indium(III)
  107. Synthesis and characterization of dual function vanadyl, gallium and indium curcumin complexes for medicinal applications
  108. Synthesis and insulin-mimetic activities of metal complexes with 3-hydroxypyridine-2-carboxylic acid
  109. Carbohydrate-Appended 2,2‘-Dipicolylamine Metal Complexes as Potential Imaging Agents
  110. Coordination Chemistry and Insulin-Enhancing Behavior of Vanadium Complexes with Maltol C6H6O3Structural Isomers
  111. Group 13 and Lanthanide Complexes with MixedO,SAnionic Ligands Derived from Maltol
  112. New Insights into the Interactions of Serum Proteins with Bis(maltolato)oxovanadium(IV):  Transport and Biotransformation of Insulin-Enhancing Vanadium Pharmaceuticals
  113. Vanadium Complexes with MixedO,SAnionic Ligands Derived from Maltol:  Synthesis, Characterization, and Biological Studies
  114. A glucosamine–dipicolylamine conjugate of99mTc(i) and186Re(i) for use in imaging and therapy
  115. Coordination chemistry of P, O-bidentate phosphinophenolates with Ga3+ and In3+
  116. Complementary inhibition of synoviocyte, smooth muscle cell or mouse lymphoma cell proliferation by a vanadyl curcumin complex compared to curcumin alone
  117. Novel Carbohydrate-Appended Metal Complexes for Potential Use in Molecular Imaging
  118. Carbohydrate Conjugates for Molecular Imaging and Radiotherapy: 99mTc(I) and186Re(I) Tricarbonyl Complexes ofN-(2‘-Hydroxybenzyl)-2-amino-2-deoxy-d-glucose
  119. Comparison of anti-hyperglycemic effect amongst vanadium, molybdenum and other metal maltol complexes
  120. Synthesis and insulinomimetic activities of novel mono- and tetranuclear oxovanadium(IV) complexes with 3-hydroxypyridine-2-carboxylic acid
  121. Chronic glucose-lowering effects of rosiglitazone and bis(ethylmaltolato)oxovanadium(IV) in ZDF rats
  122. Boon and Bane of Metal Ions in Medicine
  123. dlfComplexes with Uniform Coordination Geometry:  Structural and Magnetic Properties of an LnNi2 Core Supported by a Heptadentate Amine Phenol Ligand
  124. Preparation and characterization of vanadyl complexes with bidentate maltol-type ligands; in vivo comparisons of anti-diabetic therapeutic potential
  125. Vanadyl−Thiazolidinedione Combination Agents for Diabetes Therapy
  126. Synthesis and solution studies of the complexes of pyrone analogue ligands with vanadium(IV) and vanadium(V)
  127. Reduction of [VO2(ma)2]-and [VO2(ema)2]-by Ascorbic Acid and Glutathione:  Kinetic Studies of Pro-Drugs for the Enhancement of Insulin Action†
  128. Two-Dimensional (2D) Pulsed Electron Paramagnetic Resonance Study of VO2+−Triphosphate Interactions:  Evidence for Tridentate Triphosphate Coordination, and Relevance To Bone Uptake and Insulin Enhancement by Vanadium Pharmaceuticals
  129. Synthesis and Solution Studies of the Complexes of Trivalent Lanthanides with the Tetraazamacrocycle TETA-(PO)2
  130. Influence of Chelation and Oxidation State on Vanadium Bioavailability, and Their Effects on Tissue Concentrations of Zinc, Copper, and Iron
  131. Unprecedented sugar-dependent in vivo antitumor activity of carbohydrate-pendant cis-diamminedichloroplatinum(II) complexes
  132. Coordination chemistry of vanadium in metallopharmaceutical candidate compounds
  133. Insulin-Enhancing Vanadium(III) Complexes
  134. [ReO(N2O2)X] Complexes:  “4 + 1”?
  135. Lanthanide Chemistry with Bis{[bis(carboxymethyl)amino]methyl}phosphinate:  What Does an Extra Phosphinate Group Do to EDTA?
  136. Sugar-Pendant Diamines
  137. Chemistry of Re withN,N‘-Bis(2-pyridylmethyl)ethylenediamine (H2pmen):  Hydrolysis, Dehydrogenation, and Ternary Complexes
  138. Effects of Sequential Replacement of −NH2by −OH in the Tripodal Tetraamine Tren on Its Acidity and Metal Ion Coordinating Properties†
  139. Proton- and lanthanide-coordinating properties of the tetraaza macrocycle (EDDA-KA)2 in aqueous solution
  140. Seven-Coordinate [ReVON4X2]+Complexes (X = O and Cl)†
  141. Coaggregation of Paramagnetic d- and f-Block Metal Ions with a Podand-Framework Amine Phenol Ligand†
  142. Homotrinuclear Lanthanide(III) Arrays:  Assembly of and Conversion from Mononuclear and Dinuclear Units†
  143. Acid–base and metal ion-binding properties of diaminopropyl D-glucopyranoside and diaminopropyl D-mannopyranoside compounds in aqueous solution
  144. Design of vanadium compounds as insulin enhancing agents
  145. In Vivo Electron Spin−Echo Envelope Modulation (ESEEM) Spectroscopy:  First Observation of Vanadyl Coordination to Phosphate in Bone
  146. Active Oxygen Species Formation in Synaptosomes Exposed to an Aluminum Chelator
  147. Glucose-lowering properties of vanadium compounds: Comparison of coordination complexes with maltol or kojic acid as ligands
  148. Selectivity among, and aggregation of, lanthanide ions
  149. Effects of low and high dose administration of bis(maltolato)oxovanadium(IV) on fa/fa Zucker rats
  150. Highly Symmetric Group 13 Metal−Phosphinato Complexes:  Multinuclear NMR (27Al, 31P, 71Ga) Determination of Stability Constants at Low pH
  151. Reaction chemistry of BMOV, bis(maltolato)oxovanadium(IV), a potent insulin mimetic agent
  152. Evidence for energy-dependent transport of aluminum out of brain extracellular fluid
  153. Increased potency of vanadium using organic ligands
  154. Pharmacokinetics of aluminum 3-hydroxypyridin-4-one complexes: implications for aluminum redistribution subsequent to chelation therapy
  155. Bis(maltolato)oxovanadium(IV) is a potent insulin mimic
  156. Potential 67Ga radiopharmaceuticals for myocardial imaging: Tris(1-aryl-3-hydroxy-2-methyl-4-pyridinonato)gallium(III) complexes
  157. General method for the synthesis of trishydroxamic acids
  158. Design and synthesis of multidentate 2-(2′-hydroxyphenyl)-2-thiazolines for biomedical application
  159. Structural characterization of the octachloroditechnetate(III) ion in its tetrabutylammonium salt